Nukkleus Operating Income vs Cost Of Revenue Analysis

NUKKW Stock   0.03  0.00  0.00%   
Nukkleus financial indicator trend analysis is infinitely more than just investigating Nukkleus recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Nukkleus is a good investment. Please check the relationship between Nukkleus Operating Income and its Cost Of Revenue accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nukkleus. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry.
For more information on how to buy Nukkleus Stock please use our How to Invest in Nukkleus guide.

Operating Income vs Cost Of Revenue

Operating Income vs Cost Of Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Nukkleus Operating Income account and Cost Of Revenue. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between Nukkleus' Operating Income and Cost Of Revenue is -0.46. Overlapping area represents the amount of variation of Operating Income that can explain the historical movement of Cost Of Revenue in the same time period over historical financial statements of Nukkleus, assuming nothing else is changed. The correlation between historical values of Nukkleus' Operating Income and Cost Of Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Operating Income of Nukkleus are associated (or correlated) with its Cost Of Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cost Of Revenue has no effect on the direction of Operating Income i.e., Nukkleus' Operating Income and Cost Of Revenue go up and down completely randomly.

Correlation Coefficient

-0.46
Relationship DirectionNegative 
Relationship StrengthVery Weak

Operating Income

Operating Income is the amount of profit realized from Nukkleus operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Nukkleus is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.

Cost Of Revenue

Cost of Revenue is found on Nukkleus income statement and represents the costs associated with goods and services Nukkleus provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.
Most indicators from Nukkleus' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Nukkleus current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nukkleus. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry.
For more information on how to buy Nukkleus Stock please use our How to Invest in Nukkleus guide.Selling General Administrative is likely to climb to about 3.4 M in 2024, whereas Sales General And Administrative To Revenue is likely to drop 0.19 in 2024.
 2021 2022 2023 2024 (projected)
Total Operating Expenses6.2M3.2M3.7M3.9M
Cost Of Revenue22.2M16.3M18.7M13.6M

Nukkleus fundamental ratios Correlations

0.910.950.980.18-0.910.980.890.77-0.290.980.950.90.010.930.48-0.60.660.95-0.890.610.50.510.990.94-0.89
0.910.960.84-0.12-0.840.850.810.6-0.590.890.960.93-0.110.820.62-0.660.850.81-0.90.680.330.370.880.83-0.79
0.950.960.880.11-0.920.890.840.74-0.410.941.00.960.030.870.59-0.680.720.87-0.940.620.30.440.920.88-0.88
0.980.840.880.19-0.870.990.880.76-0.210.960.870.82-0.020.920.4-0.530.60.96-0.820.580.60.530.990.94-0.85
0.18-0.120.110.19-0.170.170.110.450.710.130.120.180.720.110.12-0.06-0.360.26-0.22-0.320.24-0.030.170.19-0.18
-0.91-0.84-0.92-0.87-0.17-0.87-0.81-0.790.29-0.96-0.92-0.820.07-0.94-0.260.55-0.51-0.880.78-0.56-0.15-0.72-0.92-0.911.0
0.980.850.890.990.17-0.870.860.74-0.230.960.880.81-0.050.920.4-0.520.610.95-0.830.590.580.530.990.93-0.85
0.890.810.840.880.11-0.810.860.86-0.140.880.840.770.160.770.35-0.760.470.85-0.760.550.480.490.890.84-0.78
0.770.60.740.760.45-0.790.740.860.210.770.740.640.430.640.26-0.780.140.84-0.680.330.380.450.780.82-0.77
-0.29-0.59-0.41-0.210.710.29-0.23-0.140.21-0.31-0.4-0.440.68-0.36-0.350.04-0.83-0.150.35-0.530.21-0.14-0.25-0.220.27
0.980.890.940.960.13-0.960.960.880.77-0.310.930.85-0.090.970.33-0.550.610.93-0.820.650.380.660.990.94-0.94
0.950.961.00.870.12-0.920.880.840.74-0.40.930.960.050.860.58-0.690.720.86-0.930.620.290.440.920.87-0.88
0.90.930.960.820.18-0.820.810.770.64-0.440.850.960.120.780.72-0.620.780.81-0.960.550.320.260.850.81-0.78
0.01-0.110.03-0.020.720.07-0.050.160.430.68-0.090.050.12-0.250.29-0.45-0.350.06-0.17-0.360.28-0.38-0.03-0.010.11
0.930.820.870.920.11-0.940.920.770.64-0.360.970.860.78-0.250.21-0.350.590.87-0.720.670.270.750.940.9-0.94
0.480.620.590.40.12-0.260.40.350.26-0.350.330.580.720.290.21-0.510.70.4-0.80.150.39-0.450.390.35-0.2
-0.6-0.66-0.68-0.53-0.060.55-0.52-0.76-0.780.04-0.55-0.69-0.62-0.45-0.35-0.51-0.31-0.570.67-0.3-0.32-0.09-0.57-0.550.49
0.660.850.720.6-0.36-0.510.610.470.14-0.830.610.720.78-0.350.590.7-0.310.54-0.740.60.270.060.610.55-0.47
0.950.810.870.960.26-0.880.950.850.84-0.150.930.860.810.060.870.4-0.570.54-0.830.540.540.50.960.99-0.87
-0.89-0.9-0.94-0.82-0.220.78-0.83-0.76-0.680.35-0.82-0.93-0.96-0.17-0.72-0.80.67-0.74-0.83-0.41-0.43-0.15-0.84-0.810.74
0.610.680.620.58-0.32-0.560.590.550.33-0.530.650.620.55-0.360.670.15-0.30.60.54-0.410.10.530.610.64-0.53
0.50.330.30.60.24-0.150.580.480.380.210.380.290.320.280.270.39-0.320.270.54-0.430.1-0.140.510.43-0.12
0.510.370.440.53-0.03-0.720.530.490.45-0.140.660.440.26-0.380.75-0.45-0.090.060.5-0.150.53-0.140.580.57-0.76
0.990.880.920.990.17-0.920.990.890.78-0.250.990.920.85-0.030.940.39-0.570.610.96-0.840.610.510.580.95-0.9
0.940.830.880.940.19-0.910.930.840.82-0.220.940.870.81-0.010.90.35-0.550.550.99-0.810.640.430.570.95-0.9
-0.89-0.79-0.88-0.85-0.181.0-0.85-0.78-0.770.27-0.94-0.88-0.780.11-0.94-0.20.49-0.47-0.870.74-0.53-0.12-0.76-0.9-0.9
Click cells to compare fundamentals

Nukkleus Account Relationship Matchups

Nukkleus fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets203.0K3.8M16.7M18.4M21.1M22.2M
Other Current Liab5.0M4.6M3.6M7.2M8.3M8.7M
Total Current Liabilities1.3M5.2M4.6M7.5M8.6M9.0M
Total Stockholder Equity(1.3M)(1.4M)12.0M10.9M12.5M13.2M
Net Debt161.0K1.3M3.3M(364.0K)(418.6K)(397.7K)
Retained Earnings(1.5M)(1.6M)(2.5M)(14.3M)(12.9M)(12.3M)
Cash23.5K82.8K355.7K364.0K418.6K439.6K
Cash And Short Term Investments82.9K355.7K612.2K364.0K418.6K238.2K
Common Stock Shares Outstanding6.3M257.8M356.1M10.1M9.1M8.6M
Liabilities And Stockholders Equity203.0K3.8M16.7M18.4M21.1M22.2M
Total Liab1.5M5.2M4.6M7.5M8.6M9.0M
Total Current Assets203.0K3.8M3.0M3.7M4.2M4.5M
Short Long Term Debt Total181.8K243.8K1.6M3.7M4.2M4.4M
Net Receivables3.9K3.7M2.7M966.1K1.1M1.3M
Non Current Liabilities Total246.2K247.6K180.5K254.9K229.4K278.9K
Other Current Assets3.7M2.6M89.0K3.3M3.8M4.0M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Nukkleus Stock Analysis

When running Nukkleus' price analysis, check to measure Nukkleus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nukkleus is operating at the current time. Most of Nukkleus' value examination focuses on studying past and present price action to predict the probability of Nukkleus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nukkleus' price. Additionally, you may evaluate how the addition of Nukkleus to your portfolios can decrease your overall portfolio volatility.